logo

For the Inventor, By the Inventor

La Jolla, CA, United States of America

Inhibrx Biosciences, Inc.


USPTO Granted Patents = 11

Trademarks = 2

Forward Citations = 1

Loading Chart...
Loading Chart...

26 inventors (with patents filed for the assignee):

goldMedal Brendan P Eckelman (11 out of 48 patents)

silverMedal John C Timmer (10 out of 44 patents)

bronzeMedal Kyle S Jones (6 out of 6 patents)

4.  Rajay A Pandit (5 out of 11 patents)

5.  Angelica N Sanabria (5 out of 10 patents)

6.  Lucas Rascon (4 out of 7 patents)

7.  Katelyn M Willis (4 out of 14 patents)

8.  Bryan Becklund (4 out of 4 patents)

9.  Quinn L Deveraux (3 out of 39 patents)

10.  Michael D Kaplan (3 out of 6 patents)

11.  Abrahim Hussain (2 out of 10 patents)

12.  Amir S Razai (2 out of 12 patents)

13.  Mike Kaplan (2 out of 5 patents)

14.  Chelsie Macedo (2 out of 5 patents)

15.  William Crago (2 out of 7 patents)


11 patents:

1. 12421315 - CLL-1 targeted immunotherapies (2025-09-23),
2. 12365728 - DLL3 single domain antibodies and therapeutic compositions thereof (2025-07-22),
3. 12331132 - Multispecific polypeptide constructs having constrained CD3 binding and related methods and uses (2025-06-17),
4. 12331126 - OX40-binding polypeptides and uses thereof (2025-06-17),
5. 12297271 - PD-1 single domain antibodies and therapeutic compositions thereof (2025-05-13),
6. 12234297 - IgE binding proteins and uses thereof (2025-02-25),
7. 12227584 - Multivalent and multispecific OX40-binding fusion proteins (2025-02-18),
8. 12195533 - Multispecific polypeptide constructs containing a constrained CD3 binding domain and a receptor binding region and methods of using the same (2025-01-14),
9. 12187804 - Multivalent and multispecific 41BB-binding proteins (2025-01-07),
10. 12084502 - CD33-binding polypeptides and uses thereof (2024-09-10),
11. 12043667 - CLEC12a binding polypeptides and uses thereof (2024-07-23),
Company Overview
Inhibrx Biosciences, Inc. is a biotechnology company based in La Jolla, California, focused on developing innovative therapeutics for the treatment of cancer and other serious diseases. The company specializes in the design and development of biologics, including monoclonal antibodies and protein-based therapeutics, leveraging advanced technologies to create targeted treatments. Inhibrx aims to address unmet medical needs through its proprietary platforms and extensive research in the field of immuno-oncology.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

11 Patents

#36 in La Jolla, CA

#6,541 in California

#27,514 in US

#51,761 in the World

La Jolla, CA (US)
La Jolla, CA, United States of America

Inhibrx Biosciences, Inc.

Forward Citations = 1

26 inventors:

goldMedal Brendan P Eckelman (11 out of 48 patents)

silverMedal John C Timmer (10 out of 44 patents)

bronzeMedal Kyle S Jones (6 out of 6 patents)

4.  Rajay A Pandit (5 out of 11 patents)

5.  Angelica N Sanabria (5 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Inhibrx Biosciences, Inc.. Retrieved from https://idiyas.com/company/inhibrx-biosciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…